Comparison of test with antigen VIsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis;Porównanie wyników testu z antygenem VIsE (C6) oraz testów z zastosowaniem antygenów rekombinowanych u chorych na borelioze z Lyme

Polski Merkuriusz Lekarski

Volumn 23, Issue 134, 2007, Pages 95-99

  Zajkowska, Joanna M ^a   Kondrusik, Maciej ^a   Pancewicz, Sławomir A ^a   Grygorczuk, Sambor ^a   Jamiołkowski, Jacek ^b   Stalewska, Joanna ^c  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Department of Public Health ^*

^c District Emergency Services

Author keywords

Lyme borreliosis; VIsE (C6) protein

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; DIAGNOSTIC AGENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VLSE PROTEIN, BORRELIA BURGDORFERI;

ARTICLE; AUSTRIA; BLOOD; BORRELIA BURGDORFERI; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; EVALUATION; HUMAN; IMMUNOLOGY; LYME DISEASE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEROLOGY;

ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; AUSTRIA; BACTERIAL PROTEINS; BORRELIA BURGDORFERI GROUP; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPROTEINS; LYME DISEASE; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 34548550889     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Bacon R.M., Biggerstaff B.J., Schriefer M.E. i wsp.: Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VIsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered test using whole -cell lysates. J. Infect. Dis., 2003, 3, 15187, 8, 1187-1199.
2. Crother T.R., Champion C.I., Whitelegge J.P. i wsp.: Temporal analysis of the antigenic composition of Borrelia burgdorferi during infection in rabbit skin. Infect Immun 2004 72, 9, 5063-5072.
3. Eicken C., Sharma V., Klabunde T. i wsp.: Crystal structure of Lyme disease variable surface antigen VIsE of Borrelia burgdorferi. J. Biol. Chem,. 2002. 14, 277, 24, 21691-21696.
4. Fingerle V., Schulte-Spechtel U., Levin A. i wsp.: Evaluation of an ELISA based on the C6 peptide of VIsE for diagnosis of early neuroborreliosis. IX International Conference on Lyme Borreliosis and Other Tick Borne Diseases. August 18-22, 2002, NY. Abstracts.
5. Fleming R.V., Margues A.R., Klempner M.S. i wsp.: Pretreatment and post treatment assesment of the c(6) test in patients with persistent symptoms and history of Lyme borreliosis. Eur. J. Clin. Microbiol. Infect. Dis., 2004, 23, 8, 615-618.
6. Göttner G., Schulte-Spechtel U., Wilske B.: Analysis of the heterogeneity of the immunodominant surface protein VIsE among the three european genospecies of Borrelia burgdorferi sl. VII International Potsdam Symposium on Tick Borne Diseases. Berlin (Germany). 13-14 March 2003. Abstracts.
7. Hofmann H., Lorenz I., Magyar E. i wsp.: Diagnostic value of a new C6 and C10 peptide ELISA for the Serodiagnosis of early Lyme Borreliosis - comparison to The European Two-Step Protocol. VII International Potsdam Symposium on Tick Borne Diseases. Berlin (Germany). 13-14 March 2003. Abstracts.
8. Johnson B.: Advantages and limitations of testing for antibodies to B. burgdorferi sensu stricto. IX International Conference on Lyme Borreliosis and Other Tick Borne Diseases. August 18-22, 2002, NY. Abstracts.
9. Lahdenne P., Pannelius J., Saxen H. i wsp.: Improved Serodiagnosis of erythema migrans using novel recombinat borrelial BBK32 antigens. J. Med. Microbiol., 2003, 52, 563-567.
10. Levin A., Condon P., Kovalenko V.: C6 peptide ELISA for Lyme Serodiagnosis: equivalent to two tier testing? IX International Conference on Lyme Borreliosis and Other Tick Borne Diseases. August 18-22. 2002, NY. Abstracts.
11. Levin A., Talaska T., Kovalenko V.: C6 peptide ELISA: Universal assay for detection of European Lyme Borreliosis. IX International Conference on Lyme Borreliosis and Other Tick Borne Diseases. August 18-22, 2002, NY.Abstracts.
12. Levy S., O'Connor T.P., Hanscom J.L. i wsp.: Utility of an in-office C6 ELISA test kit for determination of infection status of dogs naturally exposed to Borrelia burgdorferi. Vet. Ther., 2002, 3, 3, 308-315.
13. Levy S.A., Clark K.K., Olson R.W.: Use of C6 ELISA to compare efficacy of a whole-cell bacterin and a recombinant OspA Vaccine for the prevention of naturally transmitted canine Borrelia burgdorferi infection. IX International Conference on Lyme Borreliosis and Other Tick Borne Diseases. August 18-22, 2002, NY. Abstracts.
14. Liang F.T., Aberer E., Cinco M.i wsp.: Antigenic conservation of an immunodominant invariable region of the VIsE lipoprotein among European pathogenic genospecies of B. burgdorferi. J. Infect. Dis., 2000, 182, 1455-1462.
15. Marques A.R., Martin D.S., Philipp M.T.: Evaluation of the C6 peptide enzyme-linked immunosorbent assay for individuals vaccinated with the recombinant OspA vaccine. J. Clin. Microbiol., 2002, 40, 7, 2591-2593.
16. Mc Dowell J., Sung S., Hu L.T. i wsp.: Evidence that the variable regions of the central domain of VIsE are antigenic during infection with the Lyme disease spirochetes. IX International Conference on Lyme Borreliosis and Other Tick Borne Diseases. August 18-22, 2002, NY. Abstracts.
17. O'Connor T.P., Esty K.J., Hanscom J.L. i wsp.: Dogs vaccinated with common Lyme disease vaccines do not respond to IR6 the conserved immunodominant region of the VIsE surface protein of Borrelia burgdorferi. Clin. Diagn. Lab. Immunol., 2004, 11, 3, 458-462.
18. Ohnishi J., Schneider B., Messner W.B. i wsp. Genetic variation at the VIsE locus of Borrelia burgdorferi within ticks and mice over the course of a single transmission cycle. J. Bacteriol., 2003, 185, 15, 4432-4441.
19. Panelius J., Lahdenne P., Saxen H. i wsp.: Diagnosis of Lyme borreliosis with antibodies to recombinant proteins DbpAm BBK32 and OspC and VIsE IR6Peptide. J. Neurol., 2003, 250, 11, 1318-1327.
20. Pannelius J., Lahdenne P., Saxen H. i wsp.: Improved laboratory diagnosis of Lyme neuroborreliosis with antibodies to recombinant proteins DbpA, BBK32 and OspC and VIsE IR6 protein. IX International Conference on Lyme Borreliosis and Other Tick Borne Diseases. August 18-22, 2002, NY. Abstracts.
21. Peltomaa M., McHugh., Steere A.C.: Persistence of the antibody response to the VIsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after succesful antibiotic treatment of Lyme disease. J. Inf. Dis., 2003, 187, 8, 1178-1186.
22. Peltomaa M., McHugh G., Steere A.: The VIsE(IRS) in the serodiagnosis of Lyme Facial Paralysis. Otol. Neurotol., 25, 5, 838-841.
23. Phillip M.T., Bowers L.C., Fawcet P.T. i wsp.: Antibody response to IR6, a conserved immunodominant region of the VIsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. J. Infect. Dis. 2001, 184-187.
24. Piesman J., Zeidner N.S., Schneider B.S.: Dynamic changes in Borrelia burgdorferi populations in Ixodes scapularis during transmission: studies at the mRNA level. Vector Borne Zoonotic Dis., 2003, 3, 3, 125-132.
25. Schulte-Spechtel U., Lehnert G., Wilske B., i wsp.: Significant improvement of the recombinant Borrelia Iggimmunobiot by addition of VIsE a DbpA homologue derived from B. garinii for diagnosis of early neuroboreliosis. IX International Conference on Lyme Borreliosis and Other Tick Borne Diseases. August 18-22, 2002, NY. Abstracts.
26. Wilske B.: Diagnosis of lyme borreliosis in Europe-status report. IX International Conference on Lyme Borreliosis and Other Tick Borne Diseases. August 18-22, 2002, NY. Abstracts.
27. Wilske B.: Diagnosis of Lyme boreliosis in Europe. Vector Borne Zoonotic Dis., 2003, 3, 4, 215-227.